GlassScriptPhysician profile
Andrew Renzi
NPI 1225709868
$13,027.75
in general payments reported to CMS, 2019-2025
54 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 82% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $336 · 2022: $3,455 · 2023: $3,653 · 2024: $4,520 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,169 · Education: $67.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,168.78 |
| Education | $67.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,852.79 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $1,185.43 | 2021-2023 | Xarelto |
| Novo Nordisk INC | $1,063.57 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $778.15 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $763.76 | 2022-2024 | Relistor, Xifaxan |
| Glaxosmithkline, LLC. | $662.01 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $564.30 | 2022-2024 | Mounjaro, Jardiance, Emgality |
| Otsuka America Pharmaceutical, INC. | $466.28 | 2022-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $459.55 | 2022-2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $394.33 | 2022-2025 | Xtampza, Jornay Pm, Belbuca |
| Axsome Therapeutics, INC. | $386.98 | 2024-2025 | Auvelity |
| Lundbeck LLC | $290.54 | 2022-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $269.92 | 2021-2025 | Trintellix, Gattex |
| Astellas Pharma US INC | $263.29 | 2022-2025 | Veozah, Myrbetriq |
| Xeris Pharmaceuticals, INC. | $229.31 | 2022-2024 | Gvoke Hypopen |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $199.13 | 2021-2024 | |
| Daiichi Sankyo INC. | $193.29 | 2022-2025 | Injectafer |
| Neurocrine Biosciences, INC. | $191.26 | 2023-2024 | Ingrezza |
| Amgen INC. | $190.48 | 2022-2025 | Otezla, Repatha, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.85 | 2022-2023 | Synjardy, Jardiance, Stiolto Respimat |
| Novartis Pharmaceuticals Corporation | $164.27 | 2022-2025 | |
| Aimmune Therapeutics, INC. | $153.41 | 2024-2025 | Zenpep |
| Orexo US, INC. | $150.50 | 2022-2023 | Zubsolv |
| Alkermes, INC. | $147.02 | 2022-2024 | Lybalvi |
| Sumitomo Pharma America, INC. | $120.81 | 2024-2025 | Gemtesa |
| Paratek Pharmaceuticals, INC. | $116.76 | 2022-2025 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $105.45 | 2022-2024 | |
| Indivior INC. | $102.72 | 2022-2024 | Sublocade |
| E.R. Squibb & Sons, L.L.C. | $100.79 | 2022-2024 | Eliquis, Camzyos |
| Corium, LLC | $100.78 | 2023-2025 | Azstarys |
| Amarin Pharma, INC. | $94.82 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $91.13 | 2023-2025 | Livalo, Zoryve, Seglentis |
| Valinor Pharma, LLC | $88.23 | 2023-2024 | Movantik |
| Merck Sharp & Dohme LLC | $87.40 | 2022-2023 | Verquvo, Belsomra, Lagevrio |
| Almatica Pharma LLC | $82.50 | 2021-2023 | Loreev Xr |
| Verity Pharmaceuticals INC. | $71.64 | 2024-2025 | Tlando |
| Redhill Biopharma INC. | $58.97 | 2021-2022 | |
| Shield Therapeutics INC | $58.32 | 2025 | |
| Tolmar, INC. | $58.00 | 2023-2024 | |
| Braeburn INC. | $55.47 | 2024-2025 | Brixadi |
| Nestle Healthcare Nutrition INC. | $52.47 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.27 | 2022 | |
| Ironshore Pharmaceuticals INC. | $47.61 | 2024 | |
| Phathom Pharmaceuticals, INC. | $43.87 | 2024 | Voquezna |
| Genentech USA, INC. | $31.64 | 2021-2022 | |
| Exact Sciences Corporation | $31.01 | 2023 | Cologuard Collection Kit |
| Azurity Pharmaceuticals, INC. | $24.95 | 2025 | Azmiro |
| Hologic Sales and Service, LLC | $24.14 | 2024 | Aptima |
| Evoke Pharma, INC. | $23.22 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $20.82 | 2023 | Ajovy |
| Cequr Corporation | $20.76 | 2024 | Cequr Simplicity |
| Idorsia Pharmaceuticals US INC | $20.34 | 2022 | |
| Corcept Therapeutics | $19.71 | 2023 | Korlym |
| Cipher Pharmaceuticals US LLC | $16.73 | 2025 | Spinosad, Natroba |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Renzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.